Berlin University Medicine, estimates around 30,000 people use OpenAPS, an #OpenSource technology, for automated insulin delivery.
Two randomized controlled trials have shown the safety and effectiveness of #OpenSource systems. Last January, the US Food and Drug Administration granted regulatory clearance to an AID system based on an open-source algorithm for the first time.